Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul 7;15(1):347.
doi: 10.1186/s12936-016-1379-2.

Prevalence of anti-malarial resistance genes in Dakar, Senegal from 2013 to 2014

Agathe Boussaroque  1 , Bécaye Fall  2 , Marylin Madamet  3   4   5 , Khalifa Ababacar Wade  6 , Mansour Fall  7 , Aminata Nakoulima  8 , Khadidiatou Ba Fall  9 , Pierre Dionne  10 , Nicolas Benoit  3   4   5 , Bakary Diatta  7   11 , Yaya Diemé  2 , Boubacar Wade  11 , Bruno Pradines  12   13   14   15
Affiliations

Prevalence of anti-malarial resistance genes in Dakar, Senegal from 2013 to 2014

Agathe Boussaroque et al. Malar J. .

Abstract

Background: To determine the impact of the introduction of artemisinin-based combination therapy (ACT) on parasite susceptibility, a molecular surveillance for antimalarial drug resistance was conducted on local isolates from the Hôpital Principal de Dakar between November 2013 and January 2014 and between August 2014 and December 2014.

Methods: The prevalence of genetic polymorphisms in antimalarial resistance genes (pfcrt, pfmdr1, pfdhfr and pfdhps) was evaluated in 103 isolates.

Results: The chloroquine-resistant haplotypes CVIET and CVMET were identified in 31.4 and 3.9 % of the isolates, respectively. The frequency of the pfcrt K76T mutation was increased from 29.3 % in 2013-2014 to 43.2 % in 2014. The pfmdr1 N86Y and Y184F mutations were identified in 6.1 and 53.5 % of the isolates, respectively. The pfdhfr triple mutant (S108N, N51I and C59R) was detected in the majority of the isolates (82.3 %). The prevalence of quadruple mutants (pfdhfr S108N, N51I, C59R and pfdhps A437G) was 40.4 %. One isolate (1.1 %) harboured the pfdhps mutations A437G and K540E and the pfdhfr mutations S108N, N51I and C59R.

Conclusions: Despite a decline in the prevalence of chloroquine resistance due to the official withdrawal of the drug and to the introduction of ACT, the spread of resistance to chloroquine has continued. Furthermore, susceptibility to amodiaquine may be decreased as a result of cross-resistance. The frequency of the pfmdr1 mutation N86Y declined while the Y184F mutation increased in prevalence, suggesting that selective pressure is acting on pfmdr1, leading to a high prevalence of mutations in these isolates and the lack of specific mutations. The 50.5 % prevalence of the pfmdr1 polymorphisms N86Y and Y184F suggests a decrease in lumefantrine susceptibility. Based on these results, intensive surveillance of ACT partner drugs must be conducted regularly in Senegal.

Keywords: Anti-malarial; In vitro; Malaria; Molecular marker; Plasmodium falciparum; Resistance; Senegal.

PubMed Disclaimer

References

    1. Cissé B, Sokhna C, Boulanger D, Milet J, Ba EH, Richardson K, et al. Seasonal intermittent preventive treatment with artesunate and sulfadoxine–pyrimethamine for prevention of malaria in Senegalese children: a randomized, placebo-controlled, double-blind trial. Lancet. 2006;367:659–667. doi: 10.1016/S0140-6736(06)68264-0. - DOI - PubMed
    1. Sokhna C, Cissé B, Ba EH, Milligan P, Hallett R, Sutherland C, et al. A trial of the efficacy, safety and impact on drug resistance of four drug regimens for seasonal intermittent preventive treatment for malaria in Senegalese children. PLoS One. 2008;3:1471. doi: 10.1371/journal.pone.0001471. - DOI - PMC - PubMed
    1. Cissé B, Cairns M, Faye E, NDiaye O, Faye B, Cames C, et al. Randomized trial of piperaquine with sulfadoxine–pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children. PLoS One. 2009;4:7164. doi: 10.1371/journal.pone.0007164. - DOI - PMC - PubMed
    1. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell. 2000;6:861–871. doi: 10.1016/S1097-2765(05)00077-8. - DOI - PMC - PubMed
    1. Price RN, Uhlemann AC, Brockman A, McReady R, Ashley E, Phaipun L, et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet. 2004;364:438–447. doi: 10.1016/S0140-6736(04)16767-6. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources